Skip to search formSkip to main contentSkip to account menu

glucuronoxylomannan

Known as: Glucuronomannoxylan 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cryptococcus neoformans causes life-threatening diseases mainly in immunosuppressed hosts such as AIDS patients; C. gattii causes… 
2009
2009
Glucuronoxylomannan (GXM) is the major capsular polysaccharide of Cryptococcus neoformans. It is essential for fungal virulence… 
2009
2009
The glycolytic enzyme triosephosphate isomerase (TPI; EC 5.3.1.1) of Staphylococcus aureus is a candidate adhesion molecule for… 
2007
2007
ABSTRACT The fungal pathogen Cryptococcus neoformans is killed by the bacterium Staphylococcus aureus, and the killing is… 
Highly Cited
2003
Highly Cited
2003
Disseminated infections by the opportunistic yeast Cryptococcus neoformans are characterized by accumulation in tissues of… 
1998
1998
ABSTRACT Cryptococcus neoformans NIH 409 was cultured in a defined medium containing d-[1-13C]xylose (Xyl), d-[1-13C]mannose (Man… 
Highly Cited
1995
Highly Cited
1995
Monoclonal antibody (MAb) 2H1, which binds to the capsular glucuronoxylomannan (GXM) of the fungus Cryptococcus neoformans… 
1989
1989
Mice were immunized with Cryptococcus neoformans serotype A capsular glucuronoxylomannan (GXM) conjugated to bovine serum albumin…